Clinical dose finding study on NM441 in complicated urinary tract infections

Japanese Journal of Chemotherapy

Volumn 44, Issue SUPPL. 1, 1996, Pages 451-461

  Kumazawa, Joichi ^a   Matsumoto, Tetsuro ^a   Kumamoto, Yoshiaki ^b   Hirose, Takaoki ^b   Kawada, Yukimichi ^c   Ban, Yoshihito ^c   Kamidono, Sadao ^d   Arakawa, Soichi ^d   Ohmori, Hiroyuki ^e   Kumon, Hiromi ^e   Nagayama, Ariaki ^f   Tanaka, Yutaka ^g  

^a KYUSHU UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d KOBE UNIVERSITY   (Japan)

^e OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f FUKUOKA UNIVERSITY   (Japan)

^g OKAYAMA UNIVERSITY   (Japan)

Author keywords

NM394; NM441; ofloxacin

Indexed keywords

6 FLUORO 1 METHYL 4 OXO 7 (1 PIPERAZINYL) 4H 1,3 THIAZETO[3,2 A]QUINOLINE 3 CARBOXYLIC ACID; OFLOXACIN; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ALLERGY; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; TABLET; URINARY TRACT INFECTION;

EID: 15844368454     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Morino A, Okuyama Y, Momota K, Ohyabu M, Ushimaru K : Pharmacokinetics of NM441, a new quinolone, in laboratory animals. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Anaheim, October. 1992
2. Ozaki M, et al : In vitro antibacterial activity of a new quinolone, NM394. Antimicrob Agents Chemother 35 : 2490-2495, 1991
3. Ozaki M, et al : In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrob Agents Chemother 35 : 2496-2499, 1991
4. Nakashima M, Uematsu T, Kosuge K, Okuyama Y, Morino A, Ozaki M, Takebe Y : Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers. J Clin Pharmacol 34 : 930-937, 1994
5. Chemotherapy 34: 408-441, 1986
6. Chemotherapy 29 : 76-79, 1981
7. Chemotherapy 38(S-2): 571-590, 1990
8. Chemotherapy 40(S-3): 230-248, 1992
9. Chemotherapy 41(S-5): 593-608, 1993